Immatics (IMTX) News Today $4.14 +0.17 (+4.28%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$4.45 +0.31 (+7.46%) As of 04/11/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Wellington Management Group LLP Has $74.07 Million Stake in Immatics (NASDAQ:IMTX)Wellington Management Group LLP increased its position in shares of Immatics (NASDAQ:IMTX - Free Report) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,417,892 shares of the company's stock after purcApril 7, 2025 | marketbeat.comSchroder Investment Management Group Buys 147,547 Shares of Immatics (NASDAQ:IMTX)Schroder Investment Management Group raised its position in shares of Immatics (NASDAQ:IMTX - Free Report) by 52.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 427,994 shares of the company's stock afterApril 7, 2025 | marketbeat.comBrokers Offer Predictions for Immatics FY2025 EarningsImmatics (NASDAQ:IMTX - Free Report) - Cantor Fitzgerald reduced their FY2025 EPS estimates for shares of Immatics in a research note issued on Tuesday, April 1st. Cantor Fitzgerald analyst E. Schmidt now expects that the company will earn ($1.53) per share for the year, down from their prior estApril 5, 2025 | marketbeat.comCantor Fitzgerald Lowers Earnings Estimates for ImmaticsApril 5, 2025 | americanbankingnews.comImmatics (NASDAQ:IMTX) Hits New 1-Year Low - Here's WhyImmatics (NASDAQ:IMTX) Reaches New 52-Week Low - Time to Sell?April 4, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Stock Price Down 5.7% - What's Next?Immatics (NASDAQ:IMTX) Stock Price Down 5.7% - Time to Sell?April 3, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Earns Overweight Rating from Cantor FitzgeraldApril 3, 2025 | americanbankingnews.comCantor Fitzgerald maintains overweight on Immatics stockApril 3, 2025 | uk.investing.comIs Immatics (IMTX) the Best German Stock to Buy According to Hedge Funds?April 2, 2025 | insidermonkey.comImmatics' (IMTX) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Immatics in a research report on Tuesday.April 2, 2025 | marketbeat.comQ1 Earnings Estimate for Immatics Issued By Leerink PartnrsImmatics (NASDAQ:IMTX - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Immatics in a note issued to investors on Thursday, March 27th. Leerink Partnrs analyst J. Chang forecasts that the company will post earnings per sharMarch 31, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Issues Quarterly Earnings Results, Beats Estimates By $0.51 EPSImmatics (NASDAQ:IMTX - Get Free Report) released its earnings results on Thursday. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.51. Immatics had a negative return on equity of 15.90% and a negative net margin of 47.94%. The firm had revenue of $15.67 million during the quarter, compared to analysts' expectations of $16.16 million.March 29, 2025 | marketbeat.comImmatics Full Year 2024 Earnings: Beats ExpectationsMarch 29, 2025 | finance.yahoo.comBank of America Securities Sticks to Their Buy Rating for Immatics (IMTX)March 29, 2025 | markets.businessinsider.comImmatics N.V.: Trading Below Cash, But Not Without ReasonMarch 28, 2025 | seekingalpha.comImmatics (NASDAQ:IMTX) Shares Gap Up - Here's What HappenedImmatics (NASDAQ:IMTX) Shares Gap Up - Here's What HappenedMarch 28, 2025 | marketbeat.comImmatics reports FY24 EPS EUR 0.14 vs (EUR 1.18) last yearMarch 27, 2025 | markets.businessinsider.comImmatics files $500M mixed securities shelfMarch 27, 2025 | markets.businessinsider.comImmatics Announces Full Year 2024 Financial Results and Business UpdateMarch 27, 2025 | globenewswire.comImmatics (NASDAQ:IMTX) Trading Down 5.3% - Here's What HappenedImmatics (NASDAQ:IMTX) Shares Down 5.3% - What's Next?March 22, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sees Unusually-High Trading Volume - Here's What HappenedImmatics (NASDAQ:IMTX) Sees Strong Trading Volume - Time to Buy?March 21, 2025 | marketbeat.comPlatinum Investment Management Ltd. Purchases 108,108 Shares of Immatics (NASDAQ:IMTX)Platinum Investment Management Ltd. increased its stake in shares of Immatics (NASDAQ:IMTX - Free Report) by 53.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 311,722 shares of the company's stock after purchasing an additional 108,March 20, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Trading 7.3% Higher - Should You Buy?Immatics (NASDAQ:IMTX) Trading 7.3% Higher - Time to Buy?March 18, 2025 | marketbeat.comImmatics (IMTX) Projected to Post Earnings on ThursdayImmatics (NASDAQ:IMTX) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Short Interest UpdateImmatics (NASDAQ:IMTX - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 8,820,000 shares, a decrease of 11.9% from the January 31st total of 10,010,000 shares. Based on an average daily volume of 950,000 shares, the days-to-cover ratio is presently 9.3 days.March 7, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 1-Year Low - Should You Sell?Immatics (NASDAQ:IMTX) Hits New 52-Week Low - What's Next?March 5, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 1-Year Low - What's Next?Immatics (NASDAQ:IMTX) Hits New 52-Week Low - Here's What HappenedFebruary 19, 2025 | marketbeat.comVestal Point Capital, LP Increases Stake in Immatics NVFebruary 14, 2025 | gurufocus.comT. Rowe Price Investment Management, Inc. Increases Stake in Immatics NVFebruary 14, 2025 | gurufocus.comRTW INVESTMENTS, LP Reduces Stake in Immatics NV: A Strategic Portfolio AdjustmentFebruary 14, 2025 | gurufocus.comImmatics (NASDAQ:IMTX) Trading Down 4.7% - What's Next?Immatics (NASDAQ:IMTX) Trading Down 4.7% - Here's What HappenedFebruary 11, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Reaches New 1-Year Low - What's Next?Immatics (NASDAQ:IMTX) Hits New 12-Month Low - Here's WhyFebruary 10, 2025 | marketbeat.comabrdn plc Has $2.47 Million Stock Position in Immatics (NASDAQ:IMTX)abrdn plc increased its stake in Immatics (NASDAQ:IMTX - Free Report) by 49.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 347,379 shares of the company's stock after purchasing an additional 114,479 shares during the period. abrdn plc ownedFebruary 10, 2025 | marketbeat.comInvestors in Immatics (NASDAQ:IMTX) have unfortunately lost 53% over the last yearFebruary 9, 2025 | finance.yahoo.comImmatics (NASDAQ:IMTX) Short Interest Up 13.1% in JanuaryImmatics (NASDAQ:IMTX - Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 9,570,000 shares, a growth of 13.1% from the December 31st total of 8,460,000 shares. Based on an average daily trading volume, of 772,000 shares, the days-to-cover ratio is presently 12.4 days.February 3, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Should You Sell?Immatics (NASDAQ:IMTX) Hits New 1-Year Low - Here's What HappenedJanuary 29, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Reaches New 52-Week Low - Time to Sell?Immatics (NASDAQ:IMTX) Hits New 1-Year Low - Here's WhyJanuary 22, 2025 | marketbeat.comAnalysts Offer Predictions for Immatics FY2025 EarningsImmatics (NASDAQ:IMTX - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Immatics in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will earn ($1.34) per share for the yearJanuary 22, 2025 | marketbeat.comIs Immatics N.V. (IMTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | insidermonkey.comImmatics (NASDAQ:IMTX) Sees Significant Increase in Short InterestImmatics (NASDAQ:IMTX - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 9,570,000 shares, an increase of 13.1% from the December 15th total of 8,460,000 shares. Based on an average daily trading volume, of 772,000 shares, the short-interest ratio is currently 12.4 days.January 18, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Time to Sell?Immatics (NASDAQ:IMTX) Hits New 52-Week Low - Should You Sell?January 16, 2025 | marketbeat.comDown -16.85% in 4 Weeks, Here's Why Immatics (IMTX) Looks Ripe for a TurnaroundJanuary 16, 2025 | msn.comImmatics (NASDAQ:IMTX) Shares Down 3.9% - What's Next?Immatics (NASDAQ:IMTX) Trading Down 3.9% - Here's What HappenedJanuary 15, 2025 | marketbeat.comImmatics Advances PRAME Cell Therapy and Expands Oncology PipelineJanuary 13, 2025 | tipranks.comImmatics N.V.: Considering More Engineered T Cells For CancerJanuary 12, 2025 | seekingalpha.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Here's WhyImmatics (NASDAQ:IMTX) Hits New 12-Month Low - Here's WhyJanuary 10, 2025 | marketbeat.comImmatics price target lowered to $13 from $15 at BofAJanuary 8, 2025 | markets.businessinsider.comMizuho Securities Sticks to Its Buy Rating for Immatics (IMTX)December 16, 2024 | markets.businessinsider.comImmatics Faces Termination of Key Collaboration with Bristol Myers SquibbDecember 13, 2024 | tipranks.comImmatics (NASDAQ:IMTX) Stock Price Down 4.2% - Time to Sell?Immatics (NASDAQ:IMTX) Stock Price Down 4.2% - Should You Sell?December 13, 2024 | marketbeat.com Remove Ads Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address IMTX Media Mentions By Week IMTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMTX News Sentiment▼0.450.95▲Average Medical News Sentiment IMTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMTX Articles This Week▼43▲IMTX Articles Average Week Remove Ads Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NewAmsterdam Pharma News Today Metsera News Today Arcutis Biotherapeutics News Today Recursion Pharmaceuticals News Today Denali Therapeutics News Today Harmony Biosciences News Today Beam Therapeutics News Today Galapagos News Today Centessa Pharmaceuticals News Today Agios Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMTX) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. Share Immatics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMTX Stock Free IMTX Stock Alerts